Skip to main content
Start Project

GHMAP

Class III pathway in Türkiye

TİTCK market-access overview for class iii devices. Planning intelligence only — not a regulatory determination, approval, or clinical decision support.

Source trackedTürkiye
Timelines, fees, and workflow steps on this page are illustrative market-access planning inputs. They are not legal advice, regulatory approval, or a guarantee of registration, reimbursement, or market entry. Professional review with primary-source verification is required before business use.

Regulatory metrics

Planning ranges for this country and device class. Label every figure as illustrative until sources are verified.

Regulatory pathway metrics for Class III in Türkiye
MetricValueStatus
AuthorityTurkish Medicines and Medical Devices Agency (TİTCK) / ÜTSSource tracked
Device classClass IIIExample only
Average timeline~180 days / ~6 months (illustrative)To be verified
Local representative requiredYes — Turkish Authorized RepresentativeTo be verified
Government / assessment fee~$2,000 USD (illustrative)Source required

Submission workflow

Step-by-step planning outline. Owners and sequence vary by product evidence and authority questions.

  1. 01

    Lock Class III classification rationale

    Document why the device is Class III and map required clinical / technical evidence.

    Owner: Manufacturer

  2. 02

    Secure CE Mark pathway evidence

    Ensure Notified Body CE evidence is current before Turkish filing.

    Owner: Manufacturer

  3. 03

    Appoint Turkish AR and prepare Turkish labeling

    AR appointment letter, Turkish IFU/labels, and ÜTS barcode plan.

    Owner: Manufacturer / AR

  4. 04

    Submit TİTCK dossier and ÜTS registration

    File through the AR; expect questions proportional to risk class.

    Owner: AR

  5. 05

    Maintain post-market and renewal controls

    Track registration validity, ÜTS obligations, and renewal windows.

    Owner: AR / Manufacturer

Frequently asked questions

How long does Class III Turkish registration take?
Public planning ranges often cite several months after CE readiness, but clock-stop questions and dossier quality dominate. Treat published averages as unverified planning inputs.
Does GHMAP submit to TİTCK for me?
No. GHMAP provides market-access intelligence and reviewed deliverables. Regulatory submission remains with the manufacturer and appointed local representative.

Related market-access pages

Cross-links between pathway pages, country intelligence, and certification primers.

Other Türkiye classes

Country intelligence

Broader market, reimbursement, and procurement context for Türkiye.

Open country profile

Related certifications

Convert planning into a scoped GHMAP engagement

Public pathway pages are general context. Product-specific decisions use request-first market entry packages with written scope lock before research begins.

$5,000 · 15 business days after complete intake and scope lock

Full Country Intelligence

Product-specific market-entry decision for one healthcare or MedTech product in one target country. Includes the Decision Report, Evidence & Calculations Workbook, a 60-minute analyst debrief, and one consolidated revision round.

Request Country Intelligence

$7,500 · 20 business days after complete intake and scope lock

Distributor Search & Qualification

Evidence-based distributor search for one defined MedTech or IVD product in one selected country: 10–15 screened candidates, 10 detailed assessments, and 3–5 recommended for outreach when evidence supports it.

Request Distributor Search

Prefer a shorter briefing first? Request a Regulatory Pathway Brief ($1,800).

Market entry packages

Ready to scope Türkiye?

GHMAP confirms written scope before Country Intelligence or Distributor Search research begins. Payment never auto-approves introductions or workspace access.

Start Country IntelligenceRead disclaimer

Professional review remains part of every GHMAP deliverable.